Shares of Cigna Corporation (NYSE:CI) have earned an average rating of “Buy” from the twenty ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $172.82.

A number of equities analysts recently weighed in on the stock. Jefferies Group LLC reiterated a “buy” rating and issued a $183.00 price objective on shares of Cigna Corporation in a research report on Thursday, June 8th. Royal Bank of Canada lifted their price objective on shares of Cigna Corporation from $172.00 to $177.00 and gave the company an “outperform” rating in a research report on Monday, May 15th. Cowen and Company reiterated an “outperform” rating and issued a $185.00 price objective (up from $160.00) on shares of Cigna Corporation in a research report on Thursday, June 1st. ValuEngine upgraded shares of Cigna Corporation from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Finally, CIBC boosted their target price on shares of Cigna Corporation from $174.00 to $185.00 and gave the stock an “outperform” rating in a research report on Thursday.

In other news, Director Jane E. Md Henney sold 600 shares of the company’s stock in a transaction dated Monday, April 24th. The shares were sold at an average price of $156.92, for a total transaction of $94,152.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jason D. Sadler sold 4,213 shares of the company’s stock in a transaction dated Monday, April 10th. The shares were sold at an average price of $152.01, for a total transaction of $640,418.13. Following the transaction, the insider now directly owns 36,231 shares of the company’s stock, valued at approximately $5,507,474.31. The disclosure for this sale can be found here. Insiders sold a total of 46,246 shares of company stock valued at $7,433,839 in the last three months. 1.30% of the stock is currently owned by corporate insiders.

Several hedge funds and other institutional investors have recently bought and sold shares of CI. Guardian Life Insurance Co. of America increased its position in Cigna Corporation by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock worth $145,000 after buying an additional 7 shares in the last quarter. Bronfman E.L. Rothschild L.P. boosted its stake in shares of Cigna Corporation by 1.1% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 2,112 shares of the health services provider’s stock worth $309,000 after buying an additional 22 shares during the last quarter. Boys Arnold & Co. Inc. boosted its stake in shares of Cigna Corporation by 1.8% in the first quarter. Boys Arnold & Co. Inc. now owns 1,833 shares of the health services provider’s stock worth $269,000 after buying an additional 33 shares during the last quarter. Ladenburg Thalmann Financial Services Inc. boosted its stake in shares of Cigna Corporation by 1.1% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,611 shares of the health services provider’s stock worth $485,000 after buying an additional 39 shares during the last quarter. Finally, IFP Advisors Inc boosted its stake in shares of Cigna Corporation by 1.9% in the first quarter. IFP Advisors Inc now owns 2,180 shares of the health services provider’s stock worth $319,000 after buying an additional 41 shares during the last quarter. 87.05% of the stock is owned by institutional investors.

Shares of Cigna Corporation (CI) traded up 1.08% during mid-day trading on Tuesday, hitting $169.08. 2,009,547 shares of the stock traded hands. Cigna Corporation has a 12 month low of $115.03 and a 12 month high of $170.00. The stock has a market cap of $43.29 billion, a price-to-earnings ratio of 22.57 and a beta of 0.44. The firm has a 50 day moving average of $162.47 and a 200 day moving average of $149.97.

Cigna Corporation (NYSE:CI) last posted its quarterly earnings data on Friday, May 5th. The health services provider reported $2.77 earnings per share for the quarter, beating analysts’ consensus estimates of $2.44 by $0.33. Cigna Corporation had a net margin of 6.53% and a return on equity of 16.07%. The firm had revenue of $10.39 billion for the quarter, compared to analyst estimates of $10.11 billion. During the same period last year, the firm posted $2.46 EPS. Cigna Corporation’s quarterly revenue was up 5.1% on a year-over-year basis. On average, equities analysts expect that Cigna Corporation will post $9.73 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/06/16/cigna-co-ci-receives-168-79-consensus-price-target-from-analysts-updated.html.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Receive News & Stock Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related stocks with our FREE daily email newsletter.